Stay updated on ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.2 to v3.8.0; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-01T06:32:42.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A banner announces NIH website changes and says federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    0.7%
    Check dated 2026-10-25T06:45:20.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2, reflecting a site software version update.
    Difference
    0.1%
    Check dated 2026-10-18T05:40:41.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site revision displayed in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T08:10:44.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The history shows a minor UI text change in the contact information label (capitalization) and a revision tag update from v3.6.6 to v3.7.0.
    Difference
    0.2%
    Check dated 2026-09-20T03:48:35.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    A new site revision entry, v3.6.6, is added to the study record history, replacing the prior v3.6.5 and indicating a recent system update.
    Difference
    0.1%
    Check dated 2026-08-29T23:43:56.000Z thumbnail image

Stay in the know with updates to ADG126 + Pembrolizumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADG126 + Pembrolizumab in Solid Tumors Clinical Trial page.